HLT

Lyxor STOXX Europe 600 Healthcare UCITS ETF - Acc

Latest NAV
124.9607 EUR
Performance YTD

16.6%

Assets Under Management
473m EUR
TER
0.3%
ISIN
LU1834986900
Dividend Policy
Capitalisation
Investment Objective

The Lyxor STOXX Europe 600 Healthcare UCITS ETF - Acc is a UCITS compliant exchange traded fund that aims to track the benchmark index STOXX Europe 600 Health Care Net Return EUR. The STOXX Europe 600 Health Care Net Return EUR is constituted with the largest stocks of the healthcare industry in Europe. The STOXX Europe 600 supersectors are derived from the STOXX Europe 600, which comprises 600 of the largest European stocks by free float market capitalisation. They represent the largest European companies in each of the 18 Supersectors as defined by the ICB classification (Industry Classification Benchmark). The complete construction methodology for the index is available on www.stoxx.com. Lyxor ETFs are efficient investment vehicles listed on exchange that offer transparent, liquid and low-cost exposure to the underlying benchmark index.

HLT

Lyxor STOXX Europe 600 Healthcare UCITS ETF - Acc

PERFORMANCE

Performance history

The fund’s performance track record is that of FR0010344879 Lyxor STOXX Europe 600 Healthcare UCITS ETF - Acc until 18/01/2019. This fund was absorbed by LU1834986900 Lyxor STOXX Europe 600 Healthcare UCITS ETF - Acc on 18/01/2019.

Legend:

The figures relating to [past performances / simulated past performances / past performances and simulated past performances] refer or relate to past periods and are not a reliable indicator of future results. This also applies to historical market data.

Product 1Y 3Y 5Y 10Y
Lyxor STOXX Europe 600 Healthcare UCITS ETF - Acc ETF 12.27% 12.56% 8.59% 12.5%
STOXX Europe 600 Health Care Net Return EUR Benchmark Index 12.4% 12.68% 8.75% 12.68%
Data as of 16/09/2021, Source: Lyxor International Asset Management
Product YTD 1M 3M 1Y 3Y 5Y 10Y ALL
Lyxor STOXX Europe 600 Healthcare UCITS ETF - Acc ETF 16.6% -3.12% 2.87% 12.27% 42.61% 50.91% 225.08% 255.64%
STOXX Europe 600 Health Care Net Return EUR Benchmark Index 16.65% -3.11% 2.91% 12.4% 43.07% 52.07% 230.37% 263.3%
Data as of 16/09/2021, Source: Lyxor International Asset Management
Product 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Lyxor STOXX Europe 600 Healthcare UCITS ETF - Acc ETF -1.54% 31.17% -0.63% 4.14% -8.27% 16.74% 20.76% 23.42% 15.42% 15.01%
STOXX Europe 600 Health Care Net Return EUR Benchmark Index -1.41% 31.26% -0.39% 4.36% -8.03% 17.03% 20.99% 23.52% 15.5% 15.28%
Data as of 16/09/2021, Source: Lyxor International Asset Management

NAV History

Date NAV Currency Fund AUM
16/09/2021 124.9607 EUR 475m EUR
15/09/2021 124.427 EUR 473m EUR
14/09/2021 125.2162 EUR 476m EUR
13/09/2021 124.2422 EUR 477m EUR
10/09/2021 125.0883 EUR 480m EUR

Dividend History

This fund does not distribute any dividend.

HOLDINGS

This ETF uses synthetic replication to track the performance of the index. As such, the holdings of the ETF may vary from that of the benchmark index.
You can read more about our approach to replication in our pragmatic guide to replication.

Name Currency Weight Sector Country
ROCHE HOLD CHF 14.98% Health Care Switzerland
NOVARTIS AG-REG CHF 11.98% Health Care Switzerland
ASTRAZENECA PLC GBP 9.91% Health Care United Kingdom
NOVO NORDISK A/S-B DKK 9.55% Health Care Denmark
Sanofi EUR 6.26% Health Care France
GLAXOSMITHKLINE PLC GBP 5.54% Health Care United Kingdom
LONZA GROUP AG-REG CHF 3.54% Health Care Switzerland
EssilorLuxottica SA EUR 3.4% Consumer Discretionary France
BAYER AG-REG EUR 3.01% Health Care Germany
ALCON INC CHF 2.48% Health Care Switzerland
Name Listing Currency Quantity Weight Sector Country
SAP AG EUR 373,177 9.58% Information Technology Germany
EDP-ENERGIAS DE PORTUGAL SA EUR 9.17m 9.09% Utilities Portugal
ROYAL DUTCH SHELL PLC-A SHS EUR 1.93m 7.09% Energy Netherlands
DELTA AIR LINES INC USD 993,774 7.03% Industrials United States
DEUTSCHE BANK AG-REGISTERED EUR 2.35m 5.46% Financials Germany
Tesla Inc USD 35,686 4.81% Consumer Discretionary United States
Allianz SE EUR 103,697 4.2% Financials Germany
DAIMLER AG-REGISTERED SHARES EUR 270,349 4.13% Consumer Discretionary Germany
BIOGEN INC USD 72,770 3.88% Health Care United States
MUENCHENER RUECKVER AG-REG EUR 74,799 3.84% Financials Germany
Swap Information
Basket Adjustment The basket is daily adjusted to the fund outstanding level.
Counterparty Risk Level N/A
Swap Counterparty Bank of America
Date 15/09/2021

1 week moving average of counterparty risk level

Counterparty risk level at daily adjustment time

Swap Price Component

Although past performance is no indicator of future performance, you can get an estimation of the swap price component over the last 12 months by adding the TER to the realized Tracking Difference. the price of being long the index and short the basket of securities held by the ETF (ie. the spread applicable to the index performance provided by the swap counterparty) can be understood as the swap price component. The latter can be positive or negative, depending on the following factors: Read more

Lyxor STOXX Europe 600 Healthcare UCITS ETF - Acc

1Y Tracking Difference -0.13%
Total Expense Ratio +0.3%
Swap price component estimation =0.17%

Index Information

Full Name STOXX Europe 600 Health Care Net Return EUR
Index Type Performance
Index Bloomberg Ticker SXDR
Index Currency EUR
Number of Index Components 57
Further Information www.stoxx.com/indices/
Dividend Yield (%) 2.19
Data as of 15/09/2021

ESG data

Temperature Score

BBB

ESG Rating

5.46

ESG SCORE

29.07

Carbon footprint
(tons CO2e/$M sales)

Index Composition Breakdown

Currency Breakdown

CHF 36.91%
EUR 29.03%
GBP 17.7%
DKK 15%
SEK 1.37%

Sector Breakdown

Health Care 95.19%
Consumer Discretionary 3.4%
Materials 1.41%

Countries Breakdown

Switzerland 36.91%
United Kingdom 17.37%
Denmark 15%
France 11.45%
Germany 9.84%
Netherlands 3.36%
Sweden 1.37%
Italy 1.06%
Luxembourg 1.06%
Belgium 0.91%
United States 0.69%
Spain 0.42%
Jordan 0.33%
Finland 0.25%
Data as of 15/09/2021, Source: Lyxor International Asset Management

CHARACTERISTICS

Main Fund Characteristics

ISIN LU1834986900
UCITS Yes
Share Class Currency EUR
Assets Under Management 473.4m EUR
Total Expense Ratio 0.3%
Dividend Treatment Capitalisation
Original inception date 18/08/2006
EU-SD Status Out of Scope
Fund Type SICAV
Domicile Luxembourg
Replication Method Indirect (Unfunded swap)
Umbrella AUM 12,893.2m EUR
Portfolio Managers Raphaël Dieterlen, Jean-Marc Guiot
Swap Counterparty Bank of America
Full Property of the Assets Yes
Financial Year End 31/10/2021
Inception Date 17/01/2019
Minimum Investment 1 Share
SFDR Classification 6

DISCLAIMER: This fund includes a risk of capital loss. Investors therefore may not recover all or part of their initial investment. The redemption value of this fund may be less than the amount initially invested. In a worst case scenario, investors could sustain the loss of their entire investment. Be sure to read carefully the Key Investor Information document, and the “risk factors” section of a fund’s performance to better understand the risks involved.

Trading Information

Exchange Ticker Bloomberg Listing Currency Currency Hedged Listing Date Dividend Policy ADV 3M ISIN Fund AUM in CCY
Euronext HLT FP EUR - 18/01/2019 Capitalisation 277,569EUR LU1834986900 473m EUR
SIX Swiss Ex LYHLT SW EUR - 18/01/2019 Capitalisation 119,376EUR LU1834986900 473m EUR
Xetra LHTC GY EUR - 18/01/2019 Capitalisation 51,280EUR LU1834986900 473m EUR
Borsa Italiana HLT IM EUR - 18/01/2019 Capitalisation 333,267EUR LU1834986900 473m EUR
*Related Shareclasses

Market Makers

BNP Paribas
DRW GLOBAL MARKETS LTD
Flow Traders
Optiver
Société Générale
Data provided by relevant exchanges

Passporting Information

Austria
Finland
Germany
Italy
Sweden
Netherlands
Spain
UK
Czech Republic
France
Switzerland
Singapore
Luxembourg
Denmark
Data as of 16/09/2021, Source: Lyxor International Asset Management

NEWS

Notice to Shareholders
26/02/2021

Notice to Shareholders Eligibility of the ETF for French PEA equity savings plans

Notice to Shareholders
28/01/2021

Notice to Shareholders Annual general meeting of Lyxor Index Fund

Blog
18/02/2019

Blog What’s next for European equities?